Clinical Trials

Recent pre-clinical studies show that SpFN COVID-19 vaccine elicits a potent immune response

Cancer researchers call for more transparency on who drops out of clinical trials and why

Some populations have improved representation in cancer clinical trials while others remain under-represented

New research discusses the need for engagement of BIPOC communities in infectious disease research

Investigators present studies on rare disease research that achieved negative or irreproducible results

Study shows that women are underrepresented in stroke clinical trials relative to the number who have strokes

Cancer researchers have published guidance to address how pathology is planned and delivered in clinical trials

Four out of five cancer therapies tested in Phase III trials do not achieve meaningful benefit in prolonging survival

The “Imbokodo” clinical trial posed no safety concerns but did not provide sufficient protection against HIV infection

Trial also will test pausing immunosuppressive medication to improve antibody response